Cancer
The latest news, views and analysis from the pharmaceutical industry’s frontline in the war on cancer. Updates on pharmaceutical and biotech oncology pipelines, regulatory decisions and market access news, and how healthcare systems needs to change to tackle one of the world’s biggest killers.
Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’
Phil Taylor
Array Biopharma, colorectal cancer, Oncology, Pfizer, Pierre Fabre
0 Comment
Cancer/ News/ News/ News/ Oncology/ R&D
Puma Biotechnology’s breast cancer drug approved in Europe
Piotr Wnuk
breast cancer, HER2-positive breast cancer, Puma Biotechnology
0 Comment
Cancer/ News/ News/ News/ Novartis/ Oncology/ R&D/ Top stories
Novartis succeeds where Roche failed with PI3K breast cancer drug
Cancer/ Market Access/ News/ R&D/ US
FDA approves first drug to treat rare adrenal cancer
Joy Persaud
adrenal cancer, Azedra, Oncology, Progenics Pharmaceuticals
0 Comment
Accord’s biosimilar Pelgraz poised for approval
Joy Persaud
Accord Healthcare, cancer, market access, Oncology, Pelgraz
0 Comment
Cancer/ Market Access/ News/ News/ News/ News/ Oncology/ R&D
Fotivda approved in Scotland for kidney cancer
Cancer/ News/ News/ News/ Oncology/ R&D
Roche to buy rest of genetics firm Foundation Medicine
Joy Persaud
cancer, Foundation Medicine, immunology, Oncology, Roche
0 Comment